Xeltis raised €32M in a Series D+ round in Feb 2023. The company is based in Zurich, Switzerland. Investors in the round: DaVita Venture Group, EQT Life Sciences, Grand Pharma and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €32M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
